# Subcutaneous (SC) Bortezomib-Regimens for Patients With RR MM Failing Prior IV Bortezomib-Containing Regimens

> **NCT01695330** · PHASE2 · TERMINATED · sponsor: **Oncotherapeutics** · enrollment: 5 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** Subcutaneous bortezomib

## Key facts

- **NCT ID:** NCT01695330
- **Lead sponsor:** Oncotherapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-05
- **Primary completion:** 2015-10
- **Final completion:** 2015-10
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** Terminated by Sponsor of this study.
- **Last updated:** 2017-01-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01695330

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01695330, "Subcutaneous (SC) Bortezomib-Regimens for Patients With RR MM Failing Prior IV Bortezomib-Containing Regimens". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01695330. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*